Log in

Relevant bibliographies by topics / Vitamin D, chronic kidney disease, hemodialysis, diet

Contents

Journal articles
Dissertations / Theses
Book chapters
Conference papers

Academic literature on the topic 'Vitamin D, chronic kidney disease, hemodialysis, diet'

Author: Grafiati

Published: 24 April 2022

Last updated: 30 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Vitamin D, chronic kidney disease, hemodialysis, diet.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Vitamin D, chronic kidney disease, hemodialysis, diet"

1

Murkamilov, I. T., K. A. Aitbaev, V. V. Fomin, Zh A. Murkamilova, and F. A. Yusupov. "Treatment of mineral-bone disorders in chronic kidney disease." Clinical pharmacology and therapy 29, no. 4 (2020): 85–90. http://dx.doi.org/10.32756/0869-5490-2020-4-85-90.

Full text

Abstract:

Mineral-bone disorders (MBD) in chronic kidney disease (CKD) manifest by hyperphosphatemia, vitamin D deficiency, overproduction of fibroblast growth factor-23, and secondary hyperparathyroidism. CKD-MBD also results in bone resorp-tion and ectopic calcification that is associated with an increased risk of cardiovascular events and mortality. Diet is the initial and obligatory approach to treatment for CKD-MBD. Sevelamer is frequently used for correction of hyperphosphatemia in patients with renal failure who present with calcification of arteries, adynamic bone disease and/or stably low serum

APA, Harvard, Vancouver, ISO, and other styles

2

Gravellone, Luciana, Maria Antonietta Rizzo, Valentina Martina, Nicoletta Mezzina, Anna Regalia, and Maurizio Gallieni. "Vitamin D Receptor Activators and Clinical Outcomes in Chronic Kidney Disease." International Journal of Nephrology 2011 (2011): 1–13. http://dx.doi.org/10.4061/2011/419524.

Full text

Abstract:

Vitamin D deficiency appears to be an underestimated risk factor for cardiovascular disease in patients with chronic kidney disease. Evidence from both basic science and clinical studies supports the possible protective role of vitamin D beyond its effect on mineral metabolism. Toxicity of pharmacologic doses of active vitamin D metabolites, in particular calcitriol, is mainly due to the possibility of positive calcium and phosphorus balance. Therefore, vitamin D analogs have been developed, which suppress PTH secretion and synthesis with reduced calcemic and phosphatemic effects. Observationa

APA, Harvard, Vancouver, ISO, and other styles

3

Nurjanah, Oktika, Susaldi Susaldi, and Sumedi Sumedi. "Hubungan Kepatuhan, Derajat Hipertensi dan Status Nutrisi: Obesitas dengan Defisiensi Vitamin D pada Pasien Hemodialisis." Journal of Nursing Education and Practice 1, no. 4 (2022): 108–16. http://dx.doi.org/10.53801/jnep.v1i4.68.

Full text

Abstract:

Introduction: CKD (Chronic Kidney Disease) is a gradual failure of kidney function that causes the accumulation of metabolic waste substances (uremic toxins), resulting in decreased kidney function and gradual loss of kidney function over time. Objectives: To determine the relationship between adherence, degree of hypertension, and nutritional status with vitamin d deficiency in hemodialysis patients. Method: The population of this study was all patients undergoing hemodialysis therapy in room 1 and room 2 of the Avio Prima Ciledug Hemodialysis Clinic, collecting 30 people. The sampling techni

APA, Harvard, Vancouver, ISO, and other styles

4

Shen, Yingjing. "Mini review: A reevaluation of nutritional vitamin D in the treatment of chronic kidney disease." Medicine 102, no. 43 (2023): e35811. http://dx.doi.org/10.1097/md.0000000000035811.

Full text

Abstract:

Chronic kidney disease-mineral and bone disorder is a syndrome of mineral and bone metabolism abnormalities caused by chronic kidney disease. Osteoporosis is a systemic metabolic bone disease characterized by low bone mass, disruption of bone microstructure, increased brittleness, and a higher propensity for fractures. Both of these conditions significantly affect bone metabolism and substantially increase the risk of fractures. Nutritional vitamin D is an essential trace element in the human body and an important fat-soluble vitamin. One crucial physiological role of nutritional vitamin D is

APA, Harvard, Vancouver, ISO, and other styles

5

Sireesha, Vankodoth, P. Ramya Sri, and Asiya Sultana. "Comprehensive Review of CKD-MBD: From Diagnosis to Therapeutic Interventions." International Journal of Science and Healthcare Research 9, no. 3 (2024): 290–95. http://dx.doi.org/10.52403/ijshr.20240335.

Full text

Abstract:

Globally, one of the most common diseases is chronic kidney disease, which is complex and varied. One of the complications associated with the advancement of chronic kidney disease is mineral bone disorders, which include biochemical and hormonal dysregulation. A number of biomarkers, including Fibroblast Growth Factor-23, klotho, phosphate, calcium, vitamin D, and PTH, have abnormal serum level variations that are central to the pathophysiology of chronic kidney disease-Mineral Bone Disorders. Biomarkers for essential elements and functionaries of chronic kidney disease-Mineral Bone Disorders

APA, Harvard, Vancouver, ISO, and other styles

6

Faisal, Artaria Tjempakasari, and Djoko Santoso. "Correlation between vitamin D level and FRAX score in chronic kidney disease patient on maintenance hemodialysis." Bali Medical Journal 13, no. 3 (2024): 1350–54. https://doi.org/10.15562/bmj.v13i3.5280.

Full text

Abstract:

Background: Vitamin D (Vit-D) deficiency is common in CKD on hemodialysis patients. Vitamin D deficiency can cause decreased bone density, increasing osteoporosis and fracture risk. The World Health Organization has developed a new fracture risk assessment tool (FRAX score) that has become increasingly popular in osteoporosis diagnostics and risk of fracture assessment in many countries. This study evaluates the correlation between vitamin D level and FRAX score in end-stage renal disease (ESRD) patients on hemodialysis. Method: A cross sectional study was conducted on 68 CKD patients on routi

APA, Harvard, Vancouver, ISO, and other styles

7

Kovács, László, Éva Virágh, Dóra Balogh, Bernadette Kálmán, Zoltán Lőcsei, and Erzsébet Toldy. "Clinical evaluation of two parathyroid hormone assays in the context of vitamin D supply in chronic kidney disease." Orvosi Hetilap 154, no. 51 (2013): 2025–36. http://dx.doi.org/10.1556/oh.2013.29784.

Full text

Abstract:

Introduction: Parathyroid hormone levels provide important information in chronic renal failure. Aim: To compare parathyroid hormone levels measured by two assays in correlation with vitamin D supply. Method: Parathyroid hormone and 25-hydroxi-vitamin-D were determined in 104 patients (31 patients with chronic renal failure without renal replacement therapy, 36 patients treated with peritoneal dialysis and 37 patients treated with hemodialysis). Results: Good correlation was found between results of the two parathyroid hormone methods, but the intact parathyroid hormone levels were higher than

APA, Harvard, Vancouver, ISO, and other styles

8

Mittal, SP, Harendra Singh Sandhu, and Bant Singh. "Study of Vitamin D levels in patients with Chronic Kidney Disease." Bangladesh Journal of Medical Science 17, no. 4 (2018): 652–60. http://dx.doi.org/10.3329/bjms.v17i4.38332.

Full text

Abstract:

Introduction: Apart from classical functions, vitamin D has autocrine function. Autocrine function of vitamin D has a potential impact on the morbidity and mortality in the Chronic Kidney Disease patients. This study is undertaken to observe probable modality, if present, between post Hemodialysis (HD) decrease in vitamin D levels and clinical deterioration in CKD patients.Method & Material: 63 patients (32 males and 31 females) of Stage – 5 CKD were studied. There vitamin D was estimated before and after HD on first and subsequent maintenance HDs all patients with or without comorbidities

APA, Harvard, Vancouver, ISO, and other styles

9

Kumar, Sandeep, Bhagwan Das, Santosh Kumar, Abdul Manan Junejo, Rafia Memon, and Om Lal. "Vitamin D Deficiency in End-Stage Renal Disease Patients on Maintenance Hemodialysis." Pakistan Journal of Medical and Health Sciences 16, no. 1 (2022): 365–66. http://dx.doi.org/10.53350/pjmhs22161365.

Full text

Abstract:

Objective: To determine the frequency of vitamin D deficiency in end stage renal disease patients on maintenance hemodialysis. Study Design: Descriptive Cross-Sectional study. Place and Duration of Study: Department of Nephrology, JPMC, Karachi, from 12th October, 2019 to 11th April 2020. Methodology: One hundred and thirty three patients were enrolled. Venous blood sample of each patient was taken and sent to the laboratory for measuring the vitamin D levels. Serum vitamin D levels <20 ng/ml was taken as vitamin D deficiency. Results: Eighty six (64.7%) were males while 47 (35.3%) were fem

APA, Harvard, Vancouver, ISO, and other styles

10

Chen, Xin, Yong-Ping Lu, Ting Luo, et al. "Free 25-Vitamin D Is Correlated with Cardiovascular Events in Prevalent Hemodialysis Patients but Not with Markers of Renal Mineral Bone Disease." Kidney and Blood Pressure Research 44, no. 3 (2019): 344–53. http://dx.doi.org/10.1159/000499878.

Full text

Abstract:

Free vitamin D is the biologically active form of vitamin D. Vitamin D deficiency is associated with cardiovascular disease, the most common cause of mortality in hemodialysis patients. The goal of our current study was to investigate the relation between blood concentrations of free 25-hydroxyvitamin D with cardiovascular events in end-stage chronic kidney disease patients on hemodialysis, because this is unknown so far. We measured free vitamin D levels in 117 stable consecutive prevalent patients in September as a surrogate of vitamin D exposure during the past 6 months, and recorded the nu

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Vitamin D, chronic kidney disease, hemodialysis, diet"

1

Wolf, Emily A. "Assessing the Prevalence and Characteristics of Vitamin D Deficiency in Hemodialysis Patients in a Long Term Acute Care Hospital." University of Cincinnati / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1320682123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mahdavi, Sara. "Predictors of Muscle Function in Hemodialysis Patients." Thesis, 2013. http://hdl.handle.net/1807/35650.

Full text

Abstract:

Decreased skeletal muscle function (MF) is ubiquitous in hemodialysis (HD) patients and linked to functional decline. Serum vitamin D (25-OHD) and habitual physical activity (PA) are decreased in HD and linked to reduced MF in other populations. The associations between 25-OHD, PA, and MF were investigated in 81 stable HD patients. PA intensity was quantified using accelerometery, MF using handgrip strength dynamometery, 25-OHD via serum measures, and dietary and supplementation of vitamin D intake via three-day food records. MF correlated with PA (r =0.411, p = 0.003) when controlled for body

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Vitamin D, chronic kidney disease, hemodialysis, diet"

1

Tahir, Mr Abu. "Disease of Bones and Joint." In Edited Book of Pathophysiology. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/nbennurebch16.

Full text

Abstract:

Diseases of bones and joints significantly impact mobility and quality of life, with rheumatoid arthritis, osteoporosis, and gout being prevalent conditions. Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation of the synovial joints, leading to progressive joint damage. The pathophysiology involves the immune system attacking the synovium, causing inflammation and joint destruction. Epidemiologically, RA affects about 1% of the global population, with a higher prevalence in women. Symptoms include joint pain, swelling, stiffness, and fatigue. Diagnosis is b

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Vitamin D, chronic kidney disease, hemodialysis, diet"

1

Šarac, Ivana. "The basic principles of diet therapy in the treatment of patients with associated heart and kidney diseases." In 7th International Congress of Cardionephrology KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.231s.

Full text

Abstract:

The relationship between chronic kidney disease (CKD) and cardiovascular disease (CVD) is extensively documented in the literature. Patients with CKD exhibit an elevated cardiovascular risk, often presenting edema, imbalance in electrolytes, proteins, lipoproteins, hormones (including vitamin D, parathormone, renin-angiotensin-aldosterone system), enzymes, growth factors, cytokines, endothelial dysfunction, inflammation, oxidative stress, insulin resistance, and anemia, leading to cardiovascular remodeling. This results in hypertension, arteriosclerosis, arterial and cardiac valve calcificatio

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!